lobbying_activities: 3341903

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3341903	05a138f8-0a59-4fc6-89c9-120b78ffa5f3	Q1	SUSAN B ANTHONY LIST	400935704	SUSAN B ANTHONY LIST	2025	first_quarter	PHA	Shield laws; H.R. 685 Support and Value Expectant Moms and Babies Act; Chemical abortion drugs; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; Administration Personnel; Presidential Administration Actions	HOUSE OF REPRESENTATIVES,SENATE		600000	0	0	2025-04-17T15:24:54-04:00